Showing results (61-70 of 171) with videos related to
Sort By:
Pageof 18
Cancer Research|January 26, 2002
SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24Ryoichi Ono, Tomohiko Taki, Takeshi Taketani, et al.Allergology International : Official Journal of the Japanese Society of Allergology|November 1, 2006
Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in JapanMasahiko Kato, Hirokazu Kimura, Mitsuru Seki, et al.Genes, Chromosomes & Cancer|April 22, 2004
Gene expression profiling and identification of novel prognostic marker genes in neuroblastomaJunko Takita, Masami Ishii, Shuichi Tsutsumi, et al.Blood|September 25, 2003
FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidyTakeshi Taketani, Tomohiko Taki, Kanji Sugita, et al.Genes, Chromosomes & Cancer|July 23, 2003
AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignanciesTakeshi Taketani, Tomohiko Taki, Junko Takita, et al.International Journal of Hematology|January 4, 2021
Clinical features of 35 Down syndrome patients with transient abnormal myelopoiesis at a single institutionGenki Yamato, Myoung-Ja Park, Manabu Sotomatsu, et al.International Journal of Hematology|December 17, 2013
Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesisMyoung Ja Park, Manabu Sotomatsu, Kentaro Ohki, et al.Leukemia Research|October 24, 2006
Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disordersAkira Shimada, Yasuhide Hayashi, Mizuho Ogasawara, et al.Cancer Science|June 1, 2011
Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastomaJunko Takita, Yuyan Chen, Jun Okubo, et al.Blood|December 6, 2011
CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML)Norio Shiba, Daisuke Hasegawa, Myoung-ja Park, et al.Pageof 18